Pluri Inc. Logo

Pluri Inc.

Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.

PLUR | TA

Overview

Corporate Details

ISIN(s):
US72942G2030
LEI:
Country:
Israel
Address:
Park Building No. 5, 3508409 Haifa

Description

Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-20 17:26
Form 13D/A-Yaky Yanay
English 168.9 KB
2025-05-20 17:26
Form 13D/A-Yaky Yanay
English 36.2 KB
2025-05-15 16:02
Pluri CEO Issues Shareholder Letter
English 110.5 KB
2025-05-15 16:02
Pluri CEO Issues Shareholder Letter
English 36.3 KB
2025-05-14 01:22
Form 10Q -For the quarterly period ended March 31, 2025
English 1.5 MB
2025-05-14 01:22
Form 10Q -For the quarterly period ended March 31, 2025
English 36.5 KB
2025-05-08 17:34
Notification of return to the requirements of the NASDAQ registration.
English 111.0 KB
2025-05-08 17:34
Notification of return to the requirements of the NASDAQ registration.
English 36.4 KB
2025-04-30 01:27
8K-FORM 8K - Annual Meeting Date and Change Compared to the previous Meeting
English 127.0 KB
2025-04-30 01:27
8K-FORM 8K - Annual Meeting Date and Change Compared to the previous Meeting
English 36.3 KB
2025-04-28 20:52
SCHEDULE 14A-NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held On May 23, 2025
English 1.2 MB
2025-04-28 20:52
SCHEDULE 14A-NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held On May 23, 2025
English 36.3 KB
2025-04-28 17:28
8K-Pluri Completes Strategic Acquisition of Kokomodo Ltd.
English 79.9 KB
2025-04-28 17:28
8K-Pluri Completes Strategic Acquisition of Kokomodo Ltd.
English 36.3 KB
2025-04-28 17:02
Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Co…
English 108.8 KB

Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pluri Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pluri Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ARTELO BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing therapeutics by modulating the endocannabinoid system.
United States of America
ARTL
Ascelia Pharma Logo
Biotechnology company developing and commercializing novel drugs for orphan oncology.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharmaceutical firm using its prodrug technology to treat rare diseases.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
A clinical-stage biopharma developing novel therapies for cancer and other diseases.
United States of America
AAPG
Specializes in hormone-related pharmaceuticals for internal medicine, OB/GYN, and urology.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Develops sublingual drug delivery technologies for needle-free medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
A clinical-stage biotech developing small molecule antiviral therapeutics for viral diseases.
United States of America
ASMB
Assertio Holdings, Inc. Logo
Pharmaceutical company managing branded products for neurology and orphan diseases.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company turning innovative science into value for patients.
Japan
4503
AstraZeneca PLC Logo
A global, science-led biopharmaceutical company developing prescription medicines.
United Kingdom
AZN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.